Goodwill and Other Intangibles - Additional Information (Detail) - USD ($) |
12 Months Ended | ||||
|---|---|---|---|---|---|
Oct. 27, 2016 |
Aug. 31, 2014 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Finite-Lived Intangible Assets [Line Items] | |||||
| Goodwill impairment | $ 0 | ||||
| Intangible asset impairment charges | $ 0 | $ 0 | $ 0 | ||
| CBI Merger | |||||
| Finite-Lived Intangible Assets [Line Items] | |||||
| Goodwill | $ 11,000,000.0 | ||||
| CBI Merger | Third-party originators intangible | |||||
| Finite-Lived Intangible Assets [Line Items] | |||||
| Intangible assets acquired | $ 483,000 | ||||
| CBI Merger | Core deposit intangible | |||||
| Finite-Lived Intangible Assets [Line Items] | |||||
| Intangible assets acquired | $ 2,200,000 | ||||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|